A team of Texas A&M University researchers has received a $2.3 million grant from the National Institutes of Health (NIH) to further explore a unique immunotherapy that may be the first of its kind to treat colon cancer and could be the key to treating other forms of cancer as well. Dr. Stephen Safe Texas […]
Dianne Popp keeps her faith strong despite the odds of beating lung cancer | News
Dianne Popp is keeping her faith and remains committed to doing God’s work as she always has been. This despite being told that she has little time to live. It is an unshakable faith, unimaginable for most people. But for Popp it’s easy to understand. Over the past 29 years, the retired educator has battled […]
Radon: The Invisible, Odorless Menace
Credit: Pixabay/CC0 Public Domain Radon is an invisible and odorless radioactive gas. It is naturally released from rocks, soil and water – and can become trapped inside your home, office or school. There is no known safe level of radon. Unfortunately, there are no symptoms of radon exposure as there are with carbon monoxide poisoning. […]
Dr. Fakih on tumor microenvironment differences in MSS mCRC
Marwan G. Fakih, MD, Judy & Bernard Briskin Distinguished Director of Clinical Research, Professor, Department of Medical Oncology and Therapeutic Research, Associate Director of Clinical Research, Comprehensive Cancer Center, Co-Director, Gastrointestinal Cancer Program, City of Hope, discusses a comparative analysis of the tumor microenvironment in primary tumors versus metastatic tissue in patients with microsatellite stable […]
Cancer Horoscope Today, February 2, 2023: Complicated Love Life | Astrology
CANCER (June 22 to July 22) It appears to be a moderate day for Cancer natives. The Daily Astrological Forecast says that some previous work commitments can keep you busy all day and you may not be able to attend a family event. Things can go very well on the financial front. Some deals or […]
European Cancer Plan: Commission presents first country cancer profiles under European Cancer Inequality Register – The European Sting – News and critical insights on European politics, economics, foreign affairs, business and technology
(Credit: Unsplash) This article is presented to you in association with the European Commission. Today, ahead of World Cancer Day on 4 February, the Commission and the Organization for Economic Co-operation and Development (OECD) present the first Country Cancer Profilesunder the European Cancer Inequality Register for all EU Member States, Norway and Iceland. The Profiles […]
Medicaid expansion in Southern states linked to earlier and more comprehensive breast cancer treatment
main conclusions Filling a research gap: The researchers sought to understand the impact of Medicaid expansion on breast cancer care in eight Southern states, given the large geographic disparities in health that exist in that region and the variation in Medicaid coverage. Better access to insurance and early diagnosis: Patients in Southern states that expanded […]
MD Anderson Survey Highlights for February 1, 2023
Newswise — HOUSTON — Research Highlights from the University of Texas MD Anderson Cancer Center presents the latest advances in cancer treatment, research and prevention. These advances are made possible through the seamless collaboration between MD Anderson’s world-leading physicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include results […]
World Cancer Day 2023: Common cancers in women
World Cancer Day, which falls on February 4th, is the day when people all over the world come together to raise cancer awareness. It is a public health issue and governments in different countries are trying to control it. Yes, even thinking about cancer can be scary, but being knowledgeable about it is the way […]
A look back at the January 2023 FDA news
Here’s a rundown of all the notable FDA news in the oncology space for the month of January. January was a busy month for the FDA and the field of oncology as the agency approved 5 therapies including tucatinib (Tukysa), zanubrutinib (Brukinsa), pembrolizumab (Keytruda) in the later stages of non-small cell lung cancer (NSCLC ), […]